140 Results for "

LP

" in MedChemExpress (MCE) Product Catalog:
Products (140)

140 Results for "LP" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-15516
CAS No.: 1018899-04-1
Purity:  99.63%
Synonyms: LX-4211; LP-802034
Target:  

SGLT

Research Areas:  

Metabolic Disease

Sotagliflozin (LX-4211) is a potent dual SGLT2/1 inhibitor. Antidiabetic agents.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-10521
CAS No.: 356057-34-6
Purity:  99.94%
Synonyms: SB-480848
Target:  

Phospholipase Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15849
CAS No.: 945976-43-2
Purity:  98.02%
LP-533401 is a Tryptophan hydroxylase 1 inhibitor that regulates serotonin production in the gut.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15849A
CAS No.: 1040526-12-2
Purity:  98.02%
LP-533401 hydrochloride is a tryptophan hydroxylase 1 inhibitor that regulates serotonin production in the gut.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P7045
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuIL-7; LP-1; pre-B cell factor
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P3400
CAS No.: 887255-16-5
Synonyms: LQVTDSGLYRCVIYHPP
Target:  

Peptides

Research Areas:  

Neurological Disease

LP17 (LQVTDSGLYRCVIYHPP) is a BBB-penetrable triggering receptor expressed on myeloid cells (TREM-1) inhibitory peptide. LP17 substantially alleviates ischemia-induced infarction and neuronal injury. LP17 can get access into brain and block TREM-1 .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-102004
CAS No.: 412950-08-4
Purity:  99.44%
Synonyms: SB 659032
Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM . Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P3400A
Synonyms: LQVTDSGLYRCVIYHPP TFA
Target:  

Peptides

Research Areas:  

Neurological Disease

LP17 (LQVTDSGLYRCVIYHPP) TFA is a BBB-penetrable triggering receptor expressed on myeloid cells (TREM-1) inhibitory peptide. LP17 TFA substantially alleviates ischemia-induced infarction and neuronal injury. LP17 TFA can get access into brain and block TREM-1 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-46760
CAS No.: 1799316-64-5
LP01 (Example 13) is a cationic lipid used in the delivery of biologically active agents to cells and tissues .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-117626
CAS No.: 1454555-29-3
Purity:  99.74%
LP-935509 is an orally active, potent, selective, ATP-competitive and brain-penetrant inhibitor of adaptor protein-2 associated kinase 1 (AAK1) with an IC50 of 3.3 nM and a Ki of 0.9 nM, respectively. LP-935509 is also a potent inhibitor of BIKE (IC50=14 nM) and a modest inhibitor of GAK (IC50=320 nM). LP-935509 shows antinociceptive activity. LP-935509 can be used for neuropathic pain and SARS-CoV-2 research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-111455
CAS No.: 1052147-86-0
Purity:  99.87%
Target:  

5-HT Receptor

LP-211 is a selective and blood brain barrier penetrant 5-HT7 receptor agonist, with a Ki of 0.58 nM, with high selectivity over 5-HT1A receptor (Ki, 188 nM) and D2 receptor (Ki, 142 nM).
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P3496
CAS No.: 1322711-38-5
Target:  

Pyroptosis

Research Areas:  

Inflammation/Immunology

Pep19-2.5 is an synthetic and antitoxin peptide, blocks the intracellular endotoxin signaling cascade. Pep19-2.5 inhibits signaling of lipopeptides (LP) and lipopolysaccharides (LPS) mediated by transmembrane and cytosolic pattern recognition receptors (PRRs). The signaling cascades lead to inflammation and cell pyroptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-131034
CAS No.: 1365060-22-5
Purity:  99.63%
Target:  

Wnt

Research Areas:  

Others

LP-922056 is an orally active, highly potent Notum Pectinacetylesterase inhibitor with EC50s of 21 nM, 55 nM in human and mouse cellular assay, respectively. LP-922056 significantly increases midshaft femur cortical bone thickness in mice and rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120179
CAS No.: 1454808-95-7
Purity:  99.73%
Target:  

AAK1

Research Areas:  

Neurological Disease

LP-922761 is a potent, selective and orally active adapter protein-2 associated kinase 1 (AAK1) inhibitor with IC50s of 4.8 nM and 7.6 nM in enzyme and cell assays, respectively. LP-922761 also inhibits BMP-2-inducible protein kinase (BIKE) with an IC50 of 24 nM. LP-922761 exhibits no significant activity at cyclin G-associated kinase (GAK), opioid, adrenergic α2 or GABAa receptors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P3460A
TDSRCVIGLYHPPLQVY TFA is a disordered control peptide. TDSRCVIGLYHPPLQVY TFA is a peptide containing the same amino acids as LP17 (HY-P3400) but in a different sequence order .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P3460
CAS No.: 887973-01-5
TDSRCVIGLYHPPLQVY is a disordered control peptide. TDSRCVIGLYHPPLQVY is a peptide containing the same amino acids as LP17 (HY-P3400) but in a different sequence order .
loading...
    loading...
Cat. No.: HY-152857
CAS No.: 2565656-70-2
Purity:  99.96%
Synonyms: LY3473329
Target:  

LDLR

Research Areas:  

Cardiovascular Disease

Muvalaplin (LY3473329) is an orally active, selective small molecule inhibitor of lipoprotein (a) (Lp (a)) that disrupts the initial non-covalent interaction between apo(a) and apoB100, preventing the disulphide bond and Lp(a) formation. Muvalaplin reduces the levels of Lp (a) in transgenic mice and in cynomolgus monkeys .
loading...
    loading...
Cat. No.: HY-145588
CAS No.: 1637677-22-5
Purity:  99.00%
Synonyms: INCB54707
Target:  

JAK

Research Areas:  

Inflammation/Immunology

Povorcitinib (INCB54707) is a potent and selective JAK1 inhibitor that effectively reduces abscesses and inflammatory nodules. Povorcitinib is used to study cutaneous lupus erythematosus (CLE) and lichen planus (LP) .
loading...
    loading...
Cat. No.: HY-156601
CAS No.: 2035818-24-5
Purity:  99.96%
Synonyms: LP352
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Bexicaserin (LP352) is a 5-HT2C receptor agonist with potential for studying obesity and psychiatric-related disorders (such as epilepsy) .
loading...
    loading...
Cat. No.: HY-P99965
CAS No.: 1917321-26-6
Synonyms: SKY59; RO7112689; RG-6107
Crovalimab (SKY59; RO7112689) is a novel humanized antibody against C5 in a pH-dependent manner with KDs of 15.2 nM and 16.8 μM at pH 7.4 and 5.8, respectively. Crovalimab binds human FcRn with great affinity (KD: 17 μM at pH 6.0). Crovalimab can block cleavage of C5 by the C5 convertase and inhibite the activity of a C5 variant (p.Arg885His). Crovalimab inhibits C5b-9 formation significantly in all three complement pathways, the classical pathway (CP), lectin pathway (LP), and alternative pathway (AP). Crovalimab has the potential for paroxysmal nocturnal hemoglobinuria (PNH) and complement-mediated diseases research .
loading...
    loading...